Teriflunomide is an active pharmaceutical ingredient and the active metabolite of leflunomide. It was investigated in a Phase III clinical trial for multiple sclerosis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Teriflunomide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Vilazodone hydrochloride
pharmaceutical raw material
Vilazodone
pharmaceutical raw material
Pazufloxacin mesilate
pharmaceutical raw material
Cangrelor
pharmaceutical raw material
2-Cyano-3-hydroxy-N-(4-trifluoromethylphenyl)crotonamide
pharmaceutical intermediate
The international HS code for Teriflunomide (CAS 163451-81-8) is 2926.90.
2926.90
2926 90 70
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
UTNUDOFZCWSZMS-YFHOEESVSA-N
C/C(=C(\C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F)/O
Sourcing Teriflunomide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.